In Silico Drug Discovery Market to be dominated by Growing Technological Advancements through 2027
Growing prevalence of
various diseases and technological advancements to drive the in-silico drug
discovery market in the forecast period, 2023-2027.
According to TechSci Research report, “In
Silico Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027”, the global in silico drug discovery market is
anticipated to grow at a significant rate in the forecast period, 2023-2027. The
constant surge in the number of patients suffering from chronic diseases, rising
use of cloud-based applications, and growing number of collaborations between
companies are the primary factors driving the demand for the global in silico
drug discovery market. Growing technological advancements, innovative
breakthroughs in computational chemistry, rising emphasis on reduction in
medical errors and readmission rates, and rising investments on R&D
activities are expected to influence the market demand. Also, the growing
demand for cost-effective medicines and the advent in genomics and proteomics
applications are a key factor for increasing the growth of the in-silico drug
discovery market, globally.
However, the presence of open-source software
packages for drug discovery and short time to analyze data may likely hamper
the growth of the global In Silico Drug Discovery market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "In Silico Drug Discovery Market"
The global in silico drug
discovery market is segmented into component, workflow, software type,
technology, therapeutic area, end user, and company.
Based on component, the
market is divided into software, software-as-a-service, and
consultancy-as-a-service. The
software-as-a-service segment are expected to witness
the significant growth in the upcoming years. This is because of the solution
facilitate users in data mining, data evaluation, and decision making by
offering decentralization, real-world data management, and several other
features.
Based on workflow, the
market is divided into discovery, pre-clinical tests, and clinical trials.
Based on discovery, the market is further segmented into target identification,
target validation, and lead discovery. The
discovery sub-segment is expected to hold the considerable market share. This
is due to the rising incidences of various diseases and various research and
development activities.
Based on software type, the
market is segmented into molecular modeling & de novo drug design software,
and pharmacophore modeling software. The
molecular modeling & de novo drug design software segment
is expected to witness largest market share.
Based on technology, the
market is segmented into artificial intelligence, graphics processing unit, and
others. The artificial intelligence sub-segment is expected to hold the
considerable market share. This is due to the effective usage in numerous
phases of drug discovery, such as drug design, drug screening, chemical
synthesis, , pharmacology, and drug repurposing.
Based on therapeutic area,
the market is segmented into human immunodeficiency virus (HIV), infectious
diseases, metabolic disorders, oncology disorders, and others. The oncology
disorders sub-segment is expected to hold the significant market share.
This is due to the rising incidences of various types of cancers and developments
in cancer in silico studies.
Based on end user, the market
is divided into biotechnology & pharmaceutical companies, contract research
organizations, academic & research organizations, and others. The pharmaceutical
& biotechnology companies segment is expected to witness largest
market share. This is attributed to the rising R&D expenditure by
pharmaceutical and biotechnology firms and the growing requirement for new drug
development and discovery.
Major operating companies
operating in global in silico drug discovery market are:
- Aragen Life Sciences Pvt. Ltd. (GVK
Biosciences Pvt. Ltd.)
- Curia Global, Inc. (Albany Molecular
Research Inc.)
- Charles River Laboratories
International, Inc.
- Chemical Computing Group ULC. (CCG)
- Collaborative Drug Discovery Inc. (CDD)
- e-therapeutics plc.
- Dassault Systèmes SE
- Insilico Medicine, Inc.
- Numerate, Inc.
- Schrödinger, Inc.
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to the large patient population suffering from various types of diseases. The increasing number of company collaborations, medical and R&D investment, better-established network between service providers and manufacturers, and improvised reimbursement policies are propelling the market growth. Also, growing government emphasis on healthcare infrastructure in the region are expected to propel the global in silico drug discovery market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“In Silico Drug Discovery
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2017-2027 Segmented By Component (Software, Software-as-a-Service,
Consultancy-as-a-Service), By Workflow (Discovery, Pre-Clinical Tests, Clinical
Trials), By Software Type (Molecular Modeling & De Novo Drug Design
Software, Pharmacophore Modeling Software), By Technology (Artificial
Intelligence, Graphics Processing Unit, Others), By Therapeutic Area (Human
Immunodeficiency Virus (HIV), Infectious Diseases, Metabolic Disorders,
Oncology Disorders, Others), By End User (Biotechnology & Pharmaceutical
Companies, Contract Research Organizations, Academic & Research
Organizations, Others), By Company and By Region”, has evaluated the future growth
potential of global in silico drug discovery market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global in silico drug discovery market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com